Additionally, the dual targeting of the PI3K pathway using the BKM120 (PI3K inhibitor) and TKI258 (RTK inhibitor) combination demonstrates a remarkable sensitivity across all five tested PCa cell lines, regardless of their androgen sensitivity. This evidence concerns the gene PIK3CA and posterior cortical atrophy.